Editorial

The aim of Current Drug Targets - Cardiovascular & Haematological Disorders is to provide reviews describing new and ground breaking investigative areas of research into therapy for cardiovascular and haematological disorders. Current Drug Targets - Cardiovascular & Haematological Disorders publishes review articles on recent developments in the molecular biology, genomics and biochemistry of drug targets as well as disease specific proteins, receptors, enzymes, genes and diagnosis. The articles from the past year's reviews (2004) have met these aims with outstanding papers on disintegrins, peripheral vascular disease and vascular imaging, among many other excellent reviews on other topics. We would like to thank all of our exceptional authors for their contributions. For 2005 and onwards, I will again extend an open invitation to all authors to write and submit reviews in areas of research into new, therapeutic approaches for the treatment of cardiovascular and haematological disorders. We are looking forward to a truly exceptional year for Current Drug Targets - Cardiovascular & Haematological Disorders.